Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.
In this study, we investigated whether phloroglucinol (1,3,5-trihydroxybenzene) has therapeutic effects in cellular and animal model of Parkinson's disease (PD). PD is the second most common, chronic and progressive neurodegenerative disease, and is clinically characterized with motor dysfuncti...
Main Authors: | Junghwa Ryu, Rui Zhang, Bo-Hyun Hong, Eun-Jung Yang, Kyoung Ah Kang, Moonseok Choi, Ki Cheon Kim, Su-Jin Noh, Hee Soo Kim, Nam-Ho Lee, Jin Won Hyun, Hye-Sun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3748069?pdf=render |
Similar Items
-
Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease.
by: Eun-Jeong Yang, et al.
Published: (2015-01-01) -
Phloroglucinol Exerts Protective Effects Against Oxidative Stress–Induced Cell Damage in SH-SY5Y Cells
by: Hee Soo Kim, et al.
Published: (2012-01-01) -
Phloroglucinol Inhibits Oxidative-Stress-Induced Cytotoxicity in C2C12 Murine Myoblasts through Nrf-2-Mediated Activation of HO-1
by: Cheol Park, et al.
Published: (2023-02-01) -
Protective Effect of Phloroglucinol on Oxidative Stress-Induced DNA Damage and Apoptosis through Activation of the Nrf2/HO-1 Signaling Pathway in HaCaT Human Keratinocytes
by: Cheol Park, et al.
Published: (2019-04-01) -
Phloroglucinol attenuates oligomeric amyloid beta peptide1-42-induced astrocytic activation by reducing oxidative stress
by: Eun-Jeong Yang, et al.
Published: (2021-04-01)